
AUTOLOGOUS EXOSOMES
Autologous exosomes for orthopaedics & sports medicine — tendons, ligaments, muscles and joints.
Autologous exosomes for orthopaedics & sports medicine — tendons, ligaments, muscles and joints.
Autologous exosomes for musculoskeletal medicine
Beyond aesthetics, autologous exosome-rich plasma is applied in musculoskeletal and orthopaedic medicine. Exosomes promote chondrocyte metabolism, reduce synovial inflammation and accelerate tendon remodelling, improving functional recovery.

Tendinopathies
Supports tendon remodelling and functional recovery.
Muscle Tears
Supports organised, vascularised tissue repair.
Ligament Injuries
A biological approach to soft-tissue repair.
Early Osteoarthritis
Promotes chondrocyte metabolism and reduces synovial inflammation.
How exosomes act in musculoskeletal tissue
Inflammation Resolution
Exosomes suppress pro-inflammatory cytokines (IL-1β, TNF-α) and increase anti-inflammatory mediators (IL-10, TGF-β), accelerating the transition from inflammation to remodelling.
Structural Remodelling
Fibrin, exosomes and growth factors form a temporary three-dimensional scaffold for cell migration and matrix organisation.
Pain & Inflammation
By acting on inflammatory mediators and promoting repair, autologous exosomes are positioned as a biological approach in osteoarthritis, tendinopathies and chronic soft-tissue injuries.
Exosome size and knee osteoarthritis outcomes
A 2025 study from the University of Iowa (Orthopaedic Journal of Sports Medicine) followed 58 patients with mild-to-moderate knee osteoarthritis after a single ultrasound-guided PRP injection and analysed the exosomes in each patient's PRP.
Response was linked to exosome size rather than platelet count or raw exosome concentration, and PRP exosomes were taken up by human cartilage cells in the laboratory. This study used conventional PRP, not MyExo; its message is that the character of the exosomes, which depends on preparation, matters.
Song I, Glass NA, et al. The Effect of Exosome Size in Platelet-Rich Plasma on Outcomes in Patients Treated for Knee Osteoarthritis. Orthop J Sports Med. 2025;13(9). doi:10.1177/23259671251360410
Why autologous matters
From the Patient's Own Blood
Donor-free, with no additives.
Prepared at the Point of Care
Physician-prepared, fresh, in the clinic.
Not a Cosmetic "Exosome"
Unlike cosmetic or plant-derived "exosome" products, which are typically topical and not interchangeable with human extracellular vesicles.
Bring MyExo to your orthopaedic practice.
For healthcare professionals. Product information provided by the manufacturer. Distributed by Bionics Medical in the UAE and Saudi Arabia.